HLscience Co. Ltd (239610) — Capital Reinvestment Ratio
HLscience Co. Ltd (239610) has a Capital Reinvestment Ratio of 7.14x as of September 2022, meaning it reinvests 7% of its operating cash flow (₩420.13 Million) in capital expenditures (₩3.00 Billion). Check HLscience Co. Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
HLscience Co. Ltd Capital Reinvestment Ratio (2014–2022)
This chart tracks HLscience Co. Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see HLscience Co. Ltd (239610) cash conversion ratio.
Annual Capital Reinvestment Ratio for HLscience Co. Ltd (2014–2022)
Year-by-year Capital Reinvestment Ratio for HLscience Co. Ltd from 2014 to 2022. See cash generation quality of HLscience Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.87x | ₩3.95 Billion | ₩11.34 Billion | ▲ +66.0% |
| 2021 | 1.73x | ₩10.56 Billion | ₩18.25 Billion | ▲ +1768.5% |
| 2020 | 0.09x | ₩14.97 Billion | ₩1.38 Billion | ▼ -73.7% |
| 2019 | 0.35x | ₩21.38 Billion | ₩7.51 Billion | ▲ +810.0% |
| 2018 | 0.04x | ₩13.02 Billion | ₩502.80 Million | ▼ -95.5% |
| 2017 | 0.85x | ₩5.83 Billion | ₩4.99 Billion | ▲ +10.8% |
| 2016 | 0.77x | ₩5.53 Billion | ₩4.27 Billion | ▲ +246.4% |
| 2015 | 0.22x | ₩3.10 Billion | ₩691.75 Million | ▲ +36.2% |
| 2014 | 0.16x | ₩2.31 Billion | ₩378.21 Million | — |